Insulin-like growth factor receptor 1 (IGFR-1) expression is significantly associated with longer survival in non-small cell lung cancer (NSCLC) patients treated with gefitinib

被引:0
|
作者
Cappuzzo, F.
Ceresoli, G.
Bartolini, S.
Toschi, L.
Finocchiaro, G.
Domenichini, I.
Tallini, G.
Santoro, A.
Crino, L.
Hirsch, F.
机构
[1] Bellaria Hosp, Bologna, Italy
[2] Ist Clin Humanitas, Milan, Italy
[3] CINECA, Bologna, Italy
[4] Ist Clin Humanitas, Bologna, Italy
[5] Colorado Canc Ctr, Aurora, CO USA
来源
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:335 / 335
页数:1
相关论文
共 50 条
  • [21] Targeting Non-Small Cell Lung Cancer Cells by Dual Inhibition of the Insulin Receptor and the Insulin-Like Growth Factor-1 Receptor
    Vincent, Emma E.
    Elder, Douglas J. E.
    Curwen, Jon
    Kilgour, Elaine
    Hers, Ingeborg
    Tavare, Jeremy M.
    PLOS ONE, 2013, 8 (06):
  • [22] Combined inhibition of insulin-like growth factor-1 receptor enhances the effects of gefitinib in a human non-small cell lung cancer resistant cell line
    Qi, Hui Wei
    Shen, Zan
    Fan, Li Hong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (06) : 1091 - 1095
  • [23] Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer
    Peled, Nir
    Wynes, Murry W.
    Ikeda, Norihiko
    Ohira, Tatsuo
    Yoshida, Koichi
    Qian, Jin
    Ilouze, Maya
    Brenner, Ronen
    Kato, Yasufumi
    Mascaux, Celine
    Hirsch, Fred R.
    CELLULAR ONCOLOGY, 2013, 36 (04) : 277 - 288
  • [24] Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer
    Nir Peled
    Murry W. Wynes
    Norihiko Ikeda
    Tatsuo Ohira
    Koichi Yoshida
    Jin Qian
    Maya Ilouze
    Ronen Brenner
    Yasufumi Kato
    Celine Mascaux
    Fred R. Hirsch
    Cellular Oncology, 2013, 36 : 277 - 288
  • [25] Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer
    Agullo-Ortuno, M. Teresa
    Diaz-Garcia, C. Vanesa
    Agudo-Lopez, Alba
    Perez, Carlos
    Cortijo, Ana
    Paz-Ares, Luis
    Lopez-Rios, Fernando
    Pozo, Francisco
    de Castro, Javier
    Cortes-Funes, Hernan
    Lopez Martin, Jose A.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (01) : 43 - 53
  • [26] Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer
    M. Teresa Agulló-Ortuño
    C. Vanesa Díaz-García
    Alba Agudo-López
    Carlos Pérez
    Ana Cortijo
    Luis Paz-Ares
    Fernando López-Ríos
    Francisco Pozo
    Javier de Castro
    Hernán Cortés-Funes
    José A. López Martín
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 43 - 53
  • [27] DISTINCTIVE INSULIN-LIKE GROWTH FACTOR 1 GENE COPY NUMBER AND PROTEIN EXPRESSION IN NON-SMALL CELL LUNG CANCER
    Tran, Thang N.
    Selinger, Christina I.
    Kohonen-Corish, Maija
    Mccaughan, Brian
    Kennedy, Catherine
    Toole, Sandra O.
    Cooper, Wendy A.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1080 - S1080
  • [28] Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer
    Chang, Myung Hee
    Lee, Jeeyun
    Han, Joungho
    Park, Yeon Hee
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    APMIS, 2009, 117 (12) : 861 - 869
  • [29] Celecoxib inhibits insulin-like growth factor 1 induced growth and invasion in non-small cell lung cancer
    Liu, Chen-Hui
    Bao, Hong-Guang
    Ge, Ya-Li
    Wang, Shu-Kui
    Shen, Yan
    Xu, Li
    ONCOLOGY LETTERS, 2013, 5 (06) : 1943 - 1947
  • [30] Insulin receptor expression and survival of patients with non-small cell lung cancer
    Kim, Jin-Soo
    Kim, Edward S.
    Liu, Diane
    Lee, Jack
    Solis, Luisa
    Behrens, Carmen
    Lippman, Scott
    Hong, Waun Ki
    Wistuba, Ignacio I.
    Lee, Ho-Young
    CANCER RESEARCH, 2011, 71